KRK Stock Chart & Stats
zł1038.00
--
Market closed
zł1038.00
--
Day’s Range― - ―
52-Week Rangezł748.00 - zł1,200.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)74.00
Market Cap
zł35.20B
Enterprise Valuezł29.64K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)19.3
Beta0.20
Next Earnings
Dec 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.47%
Share Statistics
EPS (TTM)19.55
Shares Outstanding32,793,450
10 Day Avg. Volume55
30 Day Avg. Volume74
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
KRK FAQ
What was Krka, d. d., Novo mesto’s price range in the past 12 months?
Krka, d. d., Novo mesto lowest stock price was zł748.00 and its highest was zł1200.00 in the past 12 months.
What is Krka, d. d., Novo mesto’s market cap?
Krka, d. d., Novo mesto’s market cap is zł35.20B.
When is Krka, d. d., Novo mesto’s upcoming earnings report date?
Krka, d. d., Novo mesto’s upcoming earnings report date is Dec 11, 2026 which is in 136 days.
How were Krka, d. d., Novo mesto’s earnings last quarter?
Krka, d. d., Novo mesto released its earnings results on Jul 23, 2026. The company reported zł19.545 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Krka, d. d., Novo mesto overvalued?
According to Wall Street analysts Krka, d. d., Novo mesto’s price is currently Overvalued.
Does Krka, d. d., Novo mesto pay dividends?
Krka, d. d., Novo mesto pays a Annually dividend of zł39.327 which represents an annual dividend yield of 3.47%. See more information on Krka, d. d., Novo mesto dividends here
What is Krka, d. d., Novo mesto’s EPS estimate?
Krka, d. d., Novo mesto’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Krka, d. d., Novo mesto have?
Krka, d. d., Novo mesto has 32,793,450 shares outstanding.
What happened to Krka, d. d., Novo mesto’s price movement after its last earnings report?
Krka, d. d., Novo mesto reported an EPS of zł19.545 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Krka, d. d., Novo mesto?
Currently, no hedge funds are holding shares in PL:KRK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Krka, d. d., Novo mesto
Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved in the research, production, promotion, and sale of various pharmaceutical goods. Its market presence spans Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and numerous other international territories. The company's offerings are categorized into prescription medications, over-the-counter products, and veterinary health solutions. Its prescription drug pipeline targets a broad spectrum of medical conditions, including cardiovascular disorders, gastrointestinal issues, central nervous system ailments, pain management, anti-infective treatments, conditions affecting blood and blood-forming organs, urological problems, diabetes, and oncology. The array of non-prescription items includes products for oral and throat care, cough and cold remedies, analgesics, nasal preparations, vitamin and mineral supplements, products designed to enhance cerebral and peripheral circulation, digestive aids, and various general healthcare products. Furthermore, Krka supplies animal health products such as anti-infectives, antiparasitics, and other specialized formulations for both livestock and companion animals. Beyond its pharmaceutical operations, the company also provides health resort and tourist services. Krka, d. d. was established in 1954 and has its corporate headquarters in Novo Mesto, Slovenia.